Landiolol has cardioprotective effects against reperfusion injury in the rat heart via the PKC1 signaling pathway

Free Radical Research

Volumn 41, Issue 7, 2007, Pages 757-769

  Takahashi, Yosuke ^a   Takemura, Shigekazu ^a   Minamiyama, Yukiko ^a   Shibata, Tohihiko ^a   Hirai, Hidekazu ^a   Sasaki, Yasuyuki ^a   Sakaguchi, Masanori ^a   Suehiro, Shigefumi ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Heart rate; Mitogen activated protein kinase; Protein kinase C

Indexed keywords

5 HYDROXYDECANOIC ACID; CHELERYTHRINE; GLIBENCLAMIDE; HEAT SHOCK PROTEIN 27; LANDIOLOL; PRAZOSIN; PROTEIN KINASE C;

ANIMAL TISSUE; ARTICLE; CELL DAMAGE; CONTROLLED STUDY; ENZYME ACTIVATION; HEART FUNCTION; HEART MUSCLE CELL; HEART MUSCLE INJURY; HEART MUSCLE ISCHEMIA; HEART PROTECTION; ISOLATED HEART; MALE; NONHUMAN; RAT; REPERFUSION INJURY; SIGNAL TRANSDUCTION;

ADRENERGIC BETA-ANTAGONISTS; ALKALOIDS; ANIMALS; BENZOPHENANTHRIDINES; CARDIOTONIC AGENTS; GLYBURIDE; HEART; ISCHEMIC PRECONDITIONING; MALE; MORPHOLINES; MYOCARDIAL ISCHEMIA; PHOSPHORYLATION; PROTEIN KINASE C-EPSILON; RATS; RATS, WISTAR; REPERFUSION INJURY; SIGNAL TRANSDUCTION; UREA;

RATTUS;

EID: 34347244604     PISSN: 10715762     EISSN: 10292470     Source Type: Journal    
DOI: 10.1080/10715760701338810     Document Type: Article

References (46)

1. Murry, CE, Jennings, RB and Reimer, KA (1986) Preconditioning with ischemia: A delay of lethal cell injury in ischemic myocardium. Circulation, 74, pp. 1124-1136.
2. Loubani, M. and Galinanes, M. (2002) Pharmacological and ischemic preconditioning of the human myocardium: Mitok(ATP) channels are upstream and p38MAPK is downstream of PKC. BMC Physiol, 2, p. 10.
3. Armstrong, SC, Liu, GS, Downey, JM and Ganote, CE (1995) Potassium channels and preconditioning of isolated rabbit cardiomyocytes: Effects of glyburide and pinacidil. J Mol Cell Cardiol, 27, pp. 1765-1774.
4. Wang, Y. and Ashraf, M. (1999) Role of protein kinase C in mitochondrial KATP channel-mediated protection against Ca2+ overload injury in rat myocardium. Circ Res, 84, pp. 1156-1165.
5. Nakano, A., Baines, CP, Kim, SO, Pelech, SL, Downey, JM, Cohen, MV and Critz, SD (2000) Ischemic preconditioning activates MAPKAPK2 in the isolated rabbit heart: Evidence for involvement of p38 MAPK. Circ Res, 86, pp. 144-151.
6. Nagarkatti, DS and Sha'afi, RI (1998) Role of p38 MAP kinase in myocardial stress. J Mol Cell Cardiol, 30, pp. 1651-1664.
7. Hedges, JC, Dechert, MA, Yamboliev, IA, Martin, JL, Hickey, E., Weber, LA and Gerthoffer, WT (1999) A role for p38(MAPK)/HSP27 pathway in smooth muscle cell migration. J Biol Chem, 274, pp. 24211-24219.
8. Martin, JL, Hickey, E., Weber, LA, Dillmann, WH and Mestril, R. (1999) Influence of phosphorylation and oligomerization on the protective role of the small heat shock protein 27 in rat adult cardiomyocytes. Gene Expr, 7, pp. 349-355.
9. Sugden, PH and Clerk, A. (1998) "Stress-responsive" mitogen-activated protein kinases (c-Jun N-terminal kinases and p38 mitogen-activated protein kinases) in the myocardium. Circ Res, 83, pp. 345-352.
10. Martin, JL, Mestril, R., Hilal-Dandan, R., Brunton, LL and Dillmann, WH (1997) Small heat shock proteins and protection against ischemic injury in cardiac myocytes. Circulation, 96, pp. 4343-4348.
11. Clerk, A., Michael, A. and Sugden, PH (1998) Stimulation of multiple mitogen-activated protein kinase sub-families by oxidative stress and phosphorylation of the small heat shock protein HSP25/27, in neonatal ventricular myocytes. Biochem J, 333, pp. 581-589.
12. Iguchi, S., Iwamura, H., Nishizaki, M., Hayashi, A., Senokuchi, K., Kobayashi, K., Sakaki, K., Hachiya, K., Ichioka, Y. and Kawamura, M. (1992) Development of a highly cardioselective ultra short-acting beta-blocker ONO-1101. Chem Pharm Bull (Tokyo), 40, pp. 1462-1469.
13. Muraki, K., Nakagawa, H., Nagano, N., Henmi, S., Kawasumi, H., Nakanishi, T., Imaizumi, K., Tokuno, T., Atsuki, K., Imaizumi, Y. and Watanabe, M. (1996) Effects of ONO-1101, a novel beta-antagonist, on action potential and membrane currents in cardiac muscle. J Pharmacol Exp Ther, 278, pp. 555-563.
14. Kurosawa, S., Kanaya, N., Niiyama, Y., Nakayama, M., Fujita, S. and Namiki, A. (2003) Landiolol, esmolol and propranolol protect from ischemia/reperfusion injury in isolated guinea pig hearts. Can J Anaesth, 50, pp. 489-494.
15. Yasuda, T., Kamiya, H., Tanaka, Y. and Watanabe, G. (2001) Ultra-short-acting cardioselective beta-blockade attenuates postischemic cardiac dysfunction in the isolated rat heart. Eur J Cardiothorac Surg, 19, pp. 647-652.
16. Rockman, HA, Koch, WJ and Lefkowitz, RJ (2002) Seven-transmembrane-spanning receptors and heart function. Nature, 415, pp. 206-212.
17. Port, JD and Bristow, MR (2001) Altered beta-adrenergic receptor gene regulation and signaling in chronic heart failure. J Mol Cell Cardiol, 33, pp. 887-905.
18. Schafer, M., Ponicke, K., Heinroth-Hoffmann, I., Brodde, OE, Piper, HM and Schluter, KD (2001) Beta-adrenoceptor stimulation attenuates the hypertrophic effect of alpha-adrenoceptor stimulation in adult rat ventricular cardiomyocytes. J Am Coll Cardiol, 37, pp. 300-307.
19. Takahashi, YST, Hirai, T., Takemura, S., Minamiyama, Y., Sakaguchi, M. and Suehiro, S. (2007) Pre-ischemic administration of landiolol prevents ischemia-reperfusion injury in the rat heart. Osaka City Journal
20. Masanori, S., Toshihiko, S., Koji, H., Hidekazu, H., Mitsuharu, H., Takanobu, A., Takeshi, I., Yasuyuki, B. and Shigefumi, S. (2004) Orally administered benidipine and manidipine prevent ischemia-reperfusion injury in the rat heart. Circ J, 68, pp. 241-246.
21. Nattel, S. (1995) Mechanisms of ischemic preconditioning in rat hearts. Involvement of alpha 1B-adrenoceptors, pertussis toxin-sensitive G proteins, and protein kinase C. Circulation, 92, pp. 2259-2265.
22. Wang, Y. and Ashraf, M. (1998) Activation of alpha1-adrenergic receptor during Ca2+ pre-conditioning elicits strong protection against Ca2+ overload injury via protein kinase C signaling pathway. J Mol Cell Cardiol, 30, pp. 2423-2435.
23. Ohnuma, Y., Miura, T., Miki, T., Tanno, M., Kuno, A., Tsuchida, A. and Shimamoto, K. (2002) Opening of mitochondrial K(ATP) channel occurs downstream of PKC-epsilon activation in the mechanism of preconditioning. Am J Physiol Heart Circ Physiol, 283, pp. H440-H447.
24. Peart, J., Willems, L. and Headrick, JP (2003) Receptor and non-receptor-dependent mechanisms of cardioprotection with adenosine. Am J Physiol Heart Circ Physiol, 284, pp. H519-H527.
25. Wang, Y., Hirai, K. and Ashraf, M. (1999) Activation of mitochondrial ATP-sensitive K(+) channel for cardiac protection against ischemic injury is dependent on protein kinase C activity. Circ Res, 85, pp. 731-741.
26. Kristiansen, SB, Henning, O., Kharbanda, RK, Nielsen-Kudsk, JE, Schmidt, MR, Redington, AN, Nielsen, TT and Botker, HE (2005) Remote preconditioning reduces ischemic injury in the explanted heart by a KATP channel-dependent mechanism. Am J Physiol Heart Circ Physiol, 288, pp. H1252-H1256.
27. Inoue, I., Nagase, H., Kishi, K. and Higuti, T. (1991) ATP-sensitive channel in the mitochondrial inner membrane. Nature, 352, pp. 244-247.
28. Gross, GJ and Fryer, RM (1999) Sarcolemmal versus mitochondrial ATP-sensitive K+ channels and myocardial preconditioning. Circ Res, 84, pp. 973-979.
29. Gross, GJ and Auchampach, JA (1992) Blockade of ATP-sensitive potassium channels prevents myocardial preconditioning in dogs. Circ Res, 70, pp. 223-233.
30. Sanada, S., Kitakaze, M., Papst, PJ, Hatanaka, K., Asanuma, H., Aki, T., Shinozaki, Y., Ogita, H., Node, K., Takashima, S., Asakura, M., Yamada, J., Fukushima, T., Ogai, A., Kuzuya, T., Mori, H., Terada, N., Yoshida, K. and Hori, M. (2001) Role of phasic dynamism of p38 mitogen-activated protein kinase activation in ischemic preconditioning of the canine heart. Circ Res, 88, pp. 175-180.
31. Arnaud, C., Joyeux-Faure, M., Bottari, S., Godin-Ribuot, D. and Ribuot, C. (2004) New insight into the signalling pathways of heat stress-induced myocardial preconditioning: Protein kinase Cepsilon translocation and heat shock protein 27 phosphorylation. Clin Exp Pharmacol Physiol, 31, pp. 129-133.
32. Sanada, S., Asanuma, H., Tsukamoto, O., Minamino, T., Node, K., Takashima, S., Fukushima, T., Ogai, A., Shinozaki, Y., Fujita, M., Hirata, A., Okuda, H., Shimokawa, H., Tomoike, H., Hori, M. and Kitakaze, M. (2004) Protein kinase A as another mediator of ischemic preconditioning independent of protein kinase C. Circulation, 110, pp. 51-57.
33. Lochner, A., Genade, S., Tromp, E., Podzuweit, T. and Moolman, JA (1999) Ischemic preconditioning and the beta-adrenergic signal transduction pathway. Circulation, 100, pp. 958-966.
34. Lange, M., Smul, TM, Blomeyer, CA, Redel, A., Klotz, KN, Roewer, N. and Kehl, F. (2006) Role of the beta1-adrenergic pathway in anesthetic and ischemic preconditioning against myocardial infarction in the rabbit heart in vivo. Anesthesiology, 105, pp. 503-510.
35. Iliodromitis, EK, Tasouli, A., Andreadou, I., Bofilis, E., Zoga, A., Cokkinos, P. and Kremastinos, DT (2004) Intravenous atenolol and esmolol maintain the protective effect of ischemic preconditioning in vivo. Eur J Pharmacol, 499, pp. 163-169.
36. Mieno, S., Horimoto, H., Kishida, K., Horimoto, S. and Sasaki, S. (2006) Landiolol enhances effect of ischemic preconditioning in isolated rabbit hearts. Asian Cardiovasc Thorac Ann, 14, pp. 239-243.
37. Ichihara, K. and Abiko, Y. (1983) Effects of diltiazem and propranolol on irreversibility of ischemic cardiac function and metabolism in the isolated perfused rat heart. J Cardiovasc Pharmacol, 5, pp. 745-751.
38. Krishnan, SC and Antzelevitch, C. (1991) Sodium channel block produces opposite electrophysiological effects in canine ventricular epicardium and endocardium. Circ Res, 69, pp. 277-291.
39. Kramer, JH, Mak, IT, Freedman, AM and Weglicki, WB (1991) Propranolol reduces anoxia/reoxygenation-mediated injury of adult myocytes through an anti-radical mechanism. J Mol Cell Cardiol, 23, pp. 1231-1244.
40. Temsah, RM, Dyck, C., Netticadan, T., Chapman, D., Elimban, V. and Dhalla, NS (2000) Effect of beta-adrenoceptor blockers on sarcoplasmic reticular function and gene expression in the ischemic-reperfused heart. J Pharmacol Exp Ther, 293, pp. 15-23.
41. Bessho, R. and Chambers, DJ (2001) Myocardial protection: The efficacy of an ultra-short-acting beta-blocker, esmolol, as a cardioplegic agent. J Thorac Cardiovasc Surg, 122, pp. 993-1003.
42. Mehlhorn, U. (1997) Improved myocardial protection using continuous coronary perfusion with normothermic blood and beta-blockade with esmolol. Thorac Cardiovasc Surg, 45, pp. 224-231.
43. Zatta, AJ, Kin, H., Lee, G., Wang, N., Jiang, R., Lust, R., Reeves, JG, Mykytenko, J., Guyton, RA, Zhao, ZQ and Vinten-Johansen, J. (2006) Infarct-sparing effect of myocardial postconditioning is dependent on protein kinase C signalling. Cardiovasc Res, 70, pp. 315-324.
44. Philipp, S., Yang, XM, Cui, L., Davis, AM, Downey, JM and Cohen, MV (2006) Postconditioning protects rabbit hearts through a protein kinase C-adenosine A2b receptor cascade. Cardiovasc Res, 70, pp. 308-314.
45. Mehlhorn, U., Sauer, H., Kuhn-Regnier, F., Sudkamp, M., Dhein, S., Eberhardt, F., Grond, S., Horst, M., Hekmat, K., Geissler, HJ, Warters, RD, Allen, SJ and de Vivie, E Rainer (1999) Myocardial beta-blockade as an alternative to cardioplegic arrest during coronary artery surgery. Cardiovasc Surg, 7, pp. 549-557.
46. Yabe, K., Ishishita, H., Tanonaka, K. and Takeo, S. (1998) Pharmacologic preconditioning induced by beta-adrenergic stimulation is mediated by activation of protein kinase C. J Cardiovasc Pharmacol, 32, pp. 962-968.